Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 1
1982 1
1983 2
1984 1
1985 4
1986 1
1987 3
1988 3
1989 1
1990 1
1992 1
1993 1
1994 4
1995 2
1996 3
1997 1
1998 4
1999 1
2000 1
2001 3
2002 1
2003 1
2004 2
2006 1
2007 4
2008 4
2009 2
2011 3
2012 1
2013 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

62 results
Results by year
Filters applied: . Clear all
Page 1
Combinations of BRAF, MEK, and PI3K/mTOR inhibitors overcome acquired resistance to the BRAF inhibitor GSK2118436 dabrafenib, mediated by NRAS or MEK mutations.
Greger JG, Eastman SD, Zhang V, Bleam MR, Hughes AM, Smitheman KN, Dickerson SH, Laquerre SG, Liu L, Gilmer TM. Greger JG, et al. Among authors: gilmer tm. Mol Cancer Ther. 2012 Apr;11(4):909-20. doi: 10.1158/1535-7163.MCT-11-0989. Epub 2012 Mar 2. Mol Cancer Ther. 2012. PMID: 22389471 Free article.
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells.
Wood ER, Truesdale AT, McDonald OB, Yuan D, Hassell A, Dickerson SH, Ellis B, Pennisi C, Horne E, Lackey K, Alligood KJ, Rusnak DW, Gilmer TM, Shewchuk L. Wood ER, et al. Among authors: gilmer tm. Cancer Res. 2004 Sep 15;64(18):6652-9. doi: 10.1158/0008-5472.CAN-04-1168. Cancer Res. 2004. PMID: 15374980 Free article.
The discovery of lapatinib (GW572016).
Rusnak D, Gilmer TM. Rusnak D, et al. Among authors: gilmer tm. Mol Cancer Ther. 2011 Nov;10(11):2019. doi: 10.1158/1535-7163.MCT-11-0697. Mol Cancer Ther. 2011. PMID: 22072804 Free article. No abstract available.
Induction of gene amplification by arsenic.
Lee TC, Tanaka N, Lamb PW, Gilmer TM, Barrett JC. Lee TC, et al. Among authors: gilmer tm. Science. 1988 Jul 1;241(4861):79-81. doi: 10.1126/science.3388020. Science. 1988. PMID: 3388020
In vitro analysis of multistage carcinogenesis.
Nettesheim P, Fitzgerald DJ, Kitamura H, Walker CL, Gilmer TM, Barrett JC, Gray TE. Nettesheim P, et al. Among authors: gilmer tm. Environ Health Perspect. 1987 Nov;75:71-9. doi: 10.1289/ehp.877571. Environ Health Perspect. 1987. PMID: 3319569 Free PMC article. Review.
Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma.
Villanueva J, Infante JR, Krepler C, Reyes-Uribe P, Samanta M, Chen HY, Li B, Swoboda RK, Wilson M, Vultur A, Fukunaba-Kalabis M, Wubbenhorst B, Chen TY, Liu Q, Sproesser K, DeMarini DJ, Gilmer TM, Martin AM, Marmorstein R, Schultz DC, Speicher DW, Karakousis GC, Xu W, Amaravadi RK, Xu X, Schuchter LM, Herlyn M, Nathanson KL. Villanueva J, et al. Among authors: gilmer tm. Cell Rep. 2013 Sep 26;4(6):1090-9. doi: 10.1016/j.celrep.2013.08.023. Epub 2013 Sep 19. Cell Rep. 2013. PMID: 24055054 Free PMC article.
Characterization of human Gadd45, a p53-regulated protein.
Carrier F, Smith ML, Bae I, Kilpatrick KE, Lansing TJ, Chen CY, Engelstein M, Friend SH, Henner WD, Gilmer TM, et al. Carrier F, et al. Among authors: gilmer tm. J Biol Chem. 1994 Dec 23;269(51):32672-7. J Biol Chem. 1994. PMID: 7798274 Free article.
62 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page